chr16-89183555-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_004933.3(CDH15):c.365C>T(p.Ala122Val) variant causes a missense change. The variant allele was found at a frequency of 0.000139 in 1,614,124 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00060 ( 1 hom., cov: 32)
Exomes 𝑓: 0.000090 ( 0 hom. )
Consequence
CDH15
NM_004933.3 missense
NM_004933.3 missense
Scores
9
10
Clinical Significance
Conservation
PhyloP100: 4.43
Genes affected
CDH15 (HGNC:1754): (cadherin 15) This gene is a member of the cadherin superfamily of genes, encoding calcium-dependent intercellular adhesion glycoproteins. Cadherins consist of an extracellular domain containing 5 cadherin domains, a transmembrane region, and a conserved cytoplasmic domain. Transcripts from this particular cadherin are expressed in myoblasts and upregulated in myotubule-forming cells. The protein is thought to be essential for the control of morphogenetic processes, specifically myogenesis, and may provide a trigger for terminal muscle cell differentiation. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.025456399).
BS2
High AC in GnomAd4 at 92 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CDH15 | NM_004933.3 | c.365C>T | p.Ala122Val | missense_variant | 4/14 | ENST00000289746.3 | NP_004924.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CDH15 | ENST00000289746.3 | c.365C>T | p.Ala122Val | missense_variant | 4/14 | 1 | NM_004933.3 | ENSP00000289746.2 | ||
CDH15 | ENST00000521087.5 | n.1196C>T | non_coding_transcript_exon_variant | 3/3 | 5 | |||||
CDH15 | ENST00000524089.1 | n.430C>T | non_coding_transcript_exon_variant | 4/5 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000604 AC: 92AN: 152226Hom.: 1 Cov.: 32
GnomAD3 genomes
AF:
AC:
92
AN:
152226
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000196 AC: 49AN: 250190Hom.: 1 AF XY: 0.000126 AC XY: 17AN XY: 135436
GnomAD3 exomes
AF:
AC:
49
AN:
250190
Hom.:
AF XY:
AC XY:
17
AN XY:
135436
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000903 AC: 132AN: 1461780Hom.: 0 Cov.: 31 AF XY: 0.0000880 AC XY: 64AN XY: 727180
GnomAD4 exome
AF:
AC:
132
AN:
1461780
Hom.:
Cov.:
31
AF XY:
AC XY:
64
AN XY:
727180
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000604 AC: 92AN: 152344Hom.: 1 Cov.: 32 AF XY: 0.000550 AC XY: 41AN XY: 74504
GnomAD4 genome
AF:
AC:
92
AN:
152344
Hom.:
Cov.:
32
AF XY:
AC XY:
41
AN XY:
74504
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
8
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
34
ClinVar
Significance: Likely benign
Submissions summary: Pathogenic:1Uncertain:1Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Uncertain:1Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 18, 2017 | - - |
Uncertain significance, no assertion criteria provided | clinical testing | Department of Pathology and Laboratory Medicine, Sinai Health System | - | The CDH15 p.Ala122Val variant was identified in 1 of 1294 proband chromosomes (frequency: 0.00077) from unrelated individuals with mild to severe intellectual disability and was not identified in 1600 control chromosomes from healthy individuals (Bhalla_2008_PMID:19012874). The variant was also identified in dbSNP (ID: rs121434541) and ClinVar (classified as pathogenic by OMIM) but was not identified in Cosmic or LOVD 3.0. The variant was identified in control databases in 65 of 281588 chromosomes (1 homozygous) at a frequency of 0.000231 (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: African in 59 of 24942 chromosomes (freq: 0.002365), Latino in 5 of 35422 chromosomes (freq: 0.000141) and Other in 1 of 7216 chromosomes (freq: 0.000139), while the variant was not observed in the Ashkenazi Jewish, East Asian, European (Finnish), European (non-Finnish) or South Asian populations. Mouse L-cells transfected with CDH15 cDNA containing the A122V change demonstrated a greater than 80% decrease in cell-cell adhesion compared to cells transfected with wildtype CDH15 (Bhalla_2008_PMID:19012874). The p.Ala122 residue is conserved across mammals and other organisms, and four out of five computational analyses (PolyPhen-2, SIFT, AlignGVGD, MutationTaster) suggest that the variant may impact the protein; however, this information is not predictive enough to assume pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Intellectual disability, autosomal dominant 3 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Dec 01, 2008 | - - |
CDH15-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Dec 06, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T
M_CAP
Benign
D
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Benign
N
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D
REVEL
Uncertain
Sift
Uncertain
D
Sift4G
Uncertain
D
Polyphen
D
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at